Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
-
Field
-
computing, peer-to-peer networking, and security/privacy. How to apply Your application must include the following: • Application, stating reasons for applying and qualifications in relation to the position
-
of Electrical & Computer Engineering (ECE) invites you to apply for a 3-year researcher position (post doc level). Expected start date and duration of employment This is a 3–year position from April 1st 2026
-
the area of quantum communication and networked quantum computation, dedicated to protocols and methods for combining quantum error correction and quantum error mitigation to achieve application-level
-
good process simulation and sustainability assessment skills. The FrameBio PhD project, is part of prestigious Marie Skłodowska-Curie Actions (MSCA) Doctoral Network, a collaboration between 16 partners
-
researchers across experimental and computational fields Strong Mentorship: Active supervision and scientific development support International Outlook: Participate in global scientific networks and conferences
-
requirements and the general planning of the PhD study programme, please see DTU's rules for the PhD education . We offer you the opportunity to become part of MET2ADAPT, a doctoral network designed to equip
-
by the EU Research and Innovation programme Horizon Europe, under a grant by Marie Skłodowska-Curie Actions Doctoral Networks (MSCA-DN). The successful candidates must commence their PhD degree
-
are funded by the EU Research and Innovation programme Horizon Europe, under a grant by Marie Skłodowska-Curie Actions Doctoral Networks (MSCA-DN). The successful candidates must commence their PhD degree
-
research objectives and deliverables. As this position is funded under the Marie Skłodowska-Curie Doctoral Network (MSCA DN) programme, applicants must also meet the following eligibility criteria: Not
-
within pharmacoepidemiology and has a large international network. Furthermore, we collaborate extensively with other groups, including both clinical and basic pharmacology researchers as